STEPHAN DIETRICH A (President and CEO) purchased 10K shares of NEUBASE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $60.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/4/2020ACC: 0001104659-20-056160
DirectorOfficer· President and CEO
Since Jul 2019
+10K
Net shares
Net buyer
$60.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$6.00
Trade value
$60K
% of position
New position
4/30/2020
0.00→10K
Total
Net shares
+10K
Net value
$60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/30/2020 | P · Purchase | +10K | $6.00 | $60K | New position | 0.00 | 10K |
| Total | +10K | $60K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.55M
Total
2.55M indirect2.55M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.55M | Indirect |
| Total | 2.55M | 2.55M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported